Clinical trials

  • POLTREG-T1D for Type 1 diabetes mellitus (stage 1)|Prediabetes
  • GEMTUZUMAB OZOGAMICIN for Acute Myeloid Leukemia
  • GUSELKUMAB for Fistulizing perianal Crohn's disease
  • palbociclib for Early estrogen receptor-positive (ER+) breast cancer
  • TROSPIUM CHLORIDE; XANOMELINE TARTRATE for Psychosis associated with Alzheimer's disease
  • GUSELKUMAB for Crohn's disease
  • glofitamab for Relapsed/refractory B-cell non-Hodgkin lymphoma | Diffuse large B-cell lymphoma | High-grade B-cell lymphoma | Primary mediastinal large B-cell lymphoma | Transformed follicular lymphoma
  • INCB000928 for Fibrodysplasia Ossificans Progressiva
  • GUSELKUMAB for Crohn's disease
  • MEZIGDOMIDE for Relapsed or refractory multiple myeloma | Newly diagnosed multiple myeloma
  • IDURSULFASE for Hunter syndrome | Cognitive impairment
  • GUSELKUMAB for Crohn's disease (moderately to severely active)